Key result
Concomitant coronary artery bypass grafting during surgical repair of post-infarction mechanical complications showed no significant impact on early mortality (OR 0.96) compared to no CABG.
Why the study?
The role of concomitant coronary artery bypass grafting in the surgical treatment of mechanical complications of acute myocardial infarction is still debated.
Does concomitant CABG reduce early and late mortality in patients undergoing surgical repair of post-infarction mechanical complications?
Meta-Analysis (n=4,321)
Does concomitant CABG reduce early and late mortality in patients undergoing surgical repair of post-infarction mechanical complications?
Odds Ratio: 0.96 (95% CI 0.84–1.11)
p-value: p=0.60
Concomitant CABG during surgical repair of post-infarction mechanical complications does not significantly impact overall early or late mortality, though it may offer long-term survival benefits in patients with papillary muscle rupture.
Concomitant CABG can be performed safely without affecting early or late mortality; extends evidence for individualized decisions in these high-risk repairs.
Background: Mechanical complications of acute myocardial infarction represent life-threatening events, including ventricular septal rupture (VSR), left ventricular free-wall rupture (LVFWR) and papillary muscle rupture (PMR). In-hospital mortality is high, even when prompt surgery can be offered. The role of concomitant coronary artery bypass grafting (CABG) in the surgical treatment of these conditions is still debated. Methods: A systematic review of the literature, from 2000 onwards, about these complications was performed, analyzing data of subjects receiving versus not-receiving concomitant CABG. Primary outcome was early mortality. Secondary outcome was late mortality for hospital survivors. Subgroup analysis for VSR, LVFWR and PMR was also performed. Results: Thirty-six studies were identified, including 4,321 patients (mostly VSR-related). Preoperative coronarography was performed in 92.2% of the cases, showing single-vessel disease in 54.3% of patients. Concomitant CABG rate was 49.0%. Early mortality was 32.6% and late mortality was 40.0% with 5.2 years of mean follow-up. The analysis showed no difference in early (OR 0.96; P=0.60) or late mortality (RR 0.91; P=0.49) between CABG and non-CABG group. In subgroup analysis, concomitant CABG was associated with significantly lower mortality at long term for PMR (RR 0.42; P=0.001), although it showed a higher, but not significant, mortality in VSR (RR 1.24; P=0.20). Conclusions: Concomitant CABG in the treatment for post-infarction mechanical complications showed no significant impact on both early and late mortality, although deserving some distinctions among different types of complication and single versus multiple vessel disease. However, larger, dedicated studies are required to provide more consistent data and evidence.
No takes yet. Share an insight, caveat, or question.
Ronco et al. (2022) conducted a meta-analysis in Post-infarction mechanical complications (VSR, LVFWR, PMR) (n=4,321). Concomitant coronary artery bypass grafting (CABG) vs. No concomitant CABG was evaluated on Early mortality (OR 0.96, 95% CI 0.84-1.11, p=0.60). Concomitant coronary artery bypass grafting during surgical repair of post-infarction mechanical complications showed no significant impact on early mortality (OR 0.96) compared to no CABG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: